Likewise, the TLR9 agonist unmethylated oligonucleotide CpG, which is recognized as a bacterial DNA by TLR9, increases MMP-13 expression and activity, reduces TIMP-3 synthesis and the invasion capacity of breast MDA-MB-231 cancer cells [102]. The gene discussed is MMP13; the disease is cancer.